Market Overview

Dyax Corp. (DYAX) in Focus: Stock Up 6% - Tale of the Tape

Dyax Corp. (NASDAQ: DYAX) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session.  This reverses the recent downtrend for the company as the stock is now down about 7.14% in the past one-month time frame.

In the last 30 days, the company witnessed 2 downward estimate revision, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Dyax Corp. currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) and Aastrom Biosciences, Inc. (NASDAQ: ASTM) all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


 
ALEXION PHARMA (NASDAQ: ALXN): Free Stock Analysis Report
 
ANI PHARMACEUT (NASDAQ: ANIP): Free Stock Analysis Report
 
AASTROM BIOSCI (NASDAQ: ASTM): Get Free Report
 
DYAX CORP (NASDAQ: DYAX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

 

Related Articles (ALXN + ANIP)

Around the Web, We're Loving...

Get Benzinga's Newsletters